Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis

被引：8
|
作者：
Christopher, Karen L. [1 ]
Elner, Victor M. [1 ]
Demirci, Hakan [1 ]
机构：
[1] Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48109 USA
来源：
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY | 2017年 / 33卷 / 03期
关键词：
B-CELL LYMPHOMA; RITUXIMAB;
D O I：
10.1097/IOP.0000000000000774
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
The authors describe a 39-year-old woman treated with fingolimod for relapsing-remitting multiple sclerosis for 2 years who then developed a bilateral conjunctival mucosa-associated lymphoid tissue lymphoma. Fingolimod treatment for multiple sclerosis has been associated with lymphoma in 3 previously reported cases. This is the first case of ocular adnexal lymphoma presumed to be due to fingolimod. Given that ophthalmologists regularly monitor many patients on fingolimod for fingolimod-associated macular edema and ophthalmic manifestations of multiple sclerosis, the authors hope to alert physicians of the possibility of ocular adnexal lymphoma in these patients.
引用
收藏
页码：E73 / E75
页数：3
相关论文
共 50 条
  • [31] Fingolimod leads to early clinical and MRI benefits in relapsing-remitting multiple sclerosis
    Chin, P.
    von Rosenstiel, P.
    Haering, D.
    Francis, G.
    Kappos, L.
    JOURNAL OF NEUROLOGY, 2012, 259 : S70 - S71
  • [32] Effectiveness of fingolimod in Spanish patients with relapsing-remitting multiple sclerosis in the clinical practice
    Meca-Lallana, V.
    Martinez Yelamos, S.
    Mallada, J.
    Meca-Lallana, J.
    Martinez, M.
    Marzo, E.
    Duran, C.
    Ayuso, T.
    Barrero, F.
    Romero, R.
    Guillen, R.
    Ricart, J.
    Garcia, E.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 855 - 855
  • [33] Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosis
    Laiho, Aapo
    Laitinen, Tiina M.
    Hartikainen, Paivi
    Hartikainen, Juha E. K.
    Laitinen, Tomi P.
    Simula, Sakari
    BRAIN AND BEHAVIOR, 2018, 8 (02):
  • [34] Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
    Kuhle, Jens
    Disanto, Giulio
    Lorscheider, Johannes
    Stites, Tracy
    Chen, Yu
    Dahlke, Frank
    Francis, Gordon
    Shrinivasan, Anupama
    Radue, Ernst-Wilhelm
    Giovannoni, Gavin
    Kappos, Ludwig
    NEUROLOGY, 2015, 84 (16) : 1639 - 1643
  • [35] Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis
    Agashivala, Neetu V.
    Dastani, Homa B.
    Carlton, Rashad
    Sarnes, Evelyn
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2011, 3 (06) : 320 - 328
  • [36] Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
    Gajofatto, Alberto
    Turatti, Marco
    Monaco, Salvatore
    Benedetti, Maria Donata
    DRUG HEALTHCARE AND PATIENT SAFETY, 2015, 7 : 157 - 167
  • [37] Update on the cardiovascular profile of fingolimod in the therapy of relapsing-remitting multiple sclerosis (MS)
    Meissner, Axel
    Limmroth, Volker
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 19 - 26
  • [38] Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases
    Hakiki, Bahia
    Portaccio, Emilio
    Giannini, Marta
    Razzolini, Lorenzo
    Pasto, Luisa
    Amato, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1636 - 1639
  • [39] Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
    Kalincik, T.
    Horakova, D.
    Spelman, T.
    Jokubaitis, V.
    Trojano, M.
    Lugaresi, A.
    Izquierdo, G.
    Rozsa, C.
    Grammond, P.
    Alroughani, R.
    Duquette, P.
    Girard, M.
    Pucci, E.
    Lechner-Scott, J.
    Slee, M.
    Fernandez-Bolanos, R.
    Grand'Maison, F.
    Hupperts, R.
    Verheul, F.
    Hodgkinson, S.
    Oreja-Guevara, C.
    Spitaleri, D.
    Barnett, M.
    Terzi, M.
    Bergamaschi, R.
    McCombe, P.
    Sanchez-Menoyo, J.
    Simo, M.
    Csepany, T.
    Rum, G.
    Boz, C.
    Havrdova, E.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 195 - 196
  • [40] Alemtuzumab as alternative to patients with relapsing-remitting multiple sclerosis who failed to Fingolimod
    Lopez Real, A. M.
    Pena Martinez, J.
    Llaneza Gonzalez, M.
    Solar Sanchez, D. M.
    Garcia Estevez, D. A.
    Gonzalez Quintanilla, V.
    Pato Pato, A.
    Gonzalez Suarez, I.
    Garcia-Pelayo Rodriguez, A. M.
    Rodriguez Regal, A.
    Rodriguez Rodriguez, M.
    Suarez Moro, R.
    Arias Gomez, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 867 - 868
12345